Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features
Michal Juraska(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), James I. Mullins(University of Washington), Lennie Chen(University of Washington), Anna Yssel(University of Cape Town), Raabya Rossenkhan(Fred Hutch Cancer Center), Nonkululeko Ndabambi(University of Cape Town), Myron S. Cohen(University of North Carolina at Chapel Hill), Talita York(University of Cape Town), Dylan H. Westfall(University of Washington), Paul T. Edlefsen(Fred Hutch Cancer Center), Allan C. deCamp(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Craig A. Magaret(Fred Hutch Cancer Center), Ben Murrell(Karolinska Institutet), David Matten(University of Cape Town), Lynn Morris(National Health Laboratory Service), Carolyn Williamson(National Health Laboratory Service), Tanmoy Bhattacharya(Los Alamos National Laboratory), Nicole Espy(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Nicolas Beaume(University of Cape Town), Erika Rudnicki(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lawrence Corey(Fred Hutch Cancer Center), Alec Pankow(Karolinska Institutet), Shelly Karuna(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Morgane Rolland(Henry M. Jackson Foundation), Ruwayhida Thebus(University of Cape Town), Brian Simpkins(Pitzer College), Wenjie Deng(University of Washington), Peter B. Gilbert(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lindsay N. Carpp(Fred Hutch Cancer Center), Elena E. Giorgi(Fred Hutch Cancer Center), Kevin Gillespie(Fred Hutch Cancer Center), Hongjun Bai(Henry M. Jackson Foundation), Asanda Gwashu-Nyangiwe(University of Cape Town), Aaron Hudson(Fred Hutch Cancer Center), Brian D. Williamson(Kaiser Permanente Washington Health Research Institute), Li Li(Capital Medical University), Hong Zhao(Seattle University), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Cindy Molitor(Fred Hutch Cancer Center), David C. Montefiori(Duke University), Danica Shao(Fred Hutch Cancer Center), James P. Ludwig
Cited by 22
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
|Cell|2020|4.5k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
|New England Journal of Medicine|1990|1.3k